Citation Impact
Citing Papers
Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
2013
Targeted Degradation of KRAS by an Engineered Ubiquitin Ligase Suppresses Pancreatic Cancer Cell Growth In Vitro and In Vivo
2013
Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
2016
Cancer immunotherapies targeting the PD-1 signaling pathway
2017 StandoutNobel
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Inference and analysis of cell-cell communication using CellChat
2021 Standout
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
2017
Old dogs, new trick: classic cancer therapies activate cGAS
2020
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
2017
Head and neck squamous cell carcinoma
2020 Standout
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
2019
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
2020
The eIF2α kinases: their structures and functions
2013
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
OLA1 regulates protein synthesis and integrated stress response by inhibiting eIF2 ternary complex formation
2015
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Gene therapy in pancreatic cancer
2014
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Widespread Translational Remodeling during Human Neuronal Differentiation
2017 StandoutNobel
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
2018
Oxidative Stress in Cancer
2020 Standout
Hypoxia: Signaling the Metastatic Cascade
2016
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Targeting the translation machinery in cancer
2015
AKT/PKB Signaling: Navigating the Network
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
2017
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
2019
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
An Mtr4/ZFC3H1 complex facilitates turnover of unstable nuclear RNAs to prevent their cytoplasmic transport and global translational repression
2017
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
The integrated stress response
2016 Standout
An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response
2015
ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases
2016
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
New insights into the role of EMT in tumor immune escape
2017
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
EMT and inflammation: inseparable actors of cancer progression
2017
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly
2015
The Next Decade of Immune Checkpoint Therapy
2021 Nobel
Synthesis and cytotoxic activity of diaryl urea derivatives with a 4-methylpiperazinylcarbonyl moiety
2012
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
2022
PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy
2018
Pharmacological brake-release of mRNA translation enhances cognitive memory
2013
Tunable protein synthesis by transcript isoforms in human cells
2016 StandoutNobel
Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity
2021
Signalling to eIF4E in cancer
2015
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Works of Limo Chen being referenced
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
2016
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
2019
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
2020
The mutually regulatory loop of epithelial–mesenchymal transition and immunosuppression in cancer progression
2015
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression
2016
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target
2011
3‐Substituted Indazoles as Configurationally Locked 4EGI‐1 Mimetics and Inhibitors of the eIF4E/eIF4G Interaction
2014
Reversal of the phenotype byK-rasval12silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1
2005
In vitro inhibition of translation initiation by N,N′-diarylureas—potential anti-cancer agents
2011
Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis.
2014
Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro
2005
Synthesis of Rigidified eIF4E/eIF4G Inhibitor-1 (4EGI-1) Mimetic and Their in Vitro Characterization as Inhibitors of Protein–Protein Interaction
2014
Tumor suppression by small molecule inhibitors of translation initiation
2012